New data on stroke patients with COVID-19 | A beloved cardiologist passes away | BAV repair outcomes

It also takes longer for stroke patients to fully recover when they have COVID-19.

Willerson's research spanned decades and included topics such as unstable atherosclerotic plaques and human stem cells. He is remembered for his passion and the impact he made on those around him. 

Overall, the team behind the study noted a survival rate of 82.1% after 15 years. 

In response to the pandemic, a number of cardiovascular nonprofits have developed new patient-education materials. Here are a few.

SCAI’s president explains the key points she shares when reassuring patients who are reluctant to present for care.

Prior use of ACE inhibitors or ARBs, however, was not associated with the same changes. 

The study, published in Stroke, focused on data from more than 16,000 pairs of twins born from 1958 to 1974.

This is believed to be the first randomized clinical trial focused on treating AAAs with an angiotensin receptor blocker.

Nearly 100 doctors, scientists and health policy experts at the California institution recently took Atlas to task for his approach to the pandemic.